Kendra Lynn Sweet
Kendra Lynn Sweet publishes mostly in Hematology, Genetics and Oncology, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #1,281,949 of 7,710,434 ranked researchers
- Rank in United States
- #408,320 of 1,627,098
- Works
- 400
- Citations
- 5.6k
- Citations per work
- 14.0
What does Kendra Lynn Sweet research?
Kendra Lynn Sweet's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences27368.2%
- Medicine27368.2%
- Everything else7318.3%
- Life Sciences5413.5%
- 1Hematology38% of their works
- 2Genetics16% of their works
- 3Oncology10% of their works
- 4Molecular Biology10% of their works
- 5Immunology4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- CAR-T cell therapy research
- Acute Lymphoblastic Leukemia research
- Cutaneous lymphoproliferative disorders research
- Histone Deacetylase Inhibitors Research
Which keywords describe Kendra Lynn Sweet's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, BCR-ABL, Imatinib, JAK2 Mutation, Myelofibrosis and Chronic Lymphocytic Leukemia.
- HDAC Inhibitors
- Cutaneous Lymphomas
- Acute Lymphoblastic Leukemia
- CAR T Cells
- Chronic Lymphocytic Leukemia
- JAK2 Mutation
- BCR-ABL
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Imatinib
- Myelofibrosis
- Genomic Aberrations
- Chimeric Antigen Receptor
- Childhood Cancer
- Mycosis Fungoides
- Histone Deacetylases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Prognostic Factors3624 topics
- AML2341 topic
- Acute Myeloid Leukemia2341 topic
- BCR-ABL1041 topic
- Imatinib1041 topic
- JAK2 Mutation821 topic
- Myelofibrosis821 topic
- Chronic Lymphocytic Leukemia641 topic
- Genomic Aberrations641 topic
- CAR T Cells541 topic
- Chimeric Antigen Receptor541 topic
- Acute Lymphoblastic Leukemia341 topic
- Childhood Cancer341 topic
- Cutaneous Lymphomas301 topic
- Mycosis Fungoides301 topic
- HDAC Inhibitors291 topic
- Histone Deacetylases291 topic
Where does Kendra Lynn Sweet work?
Kendra Lynn Sweet's main affiliation in the publication record is Moffitt Cancer Center, United States.
How many publications and citations does Kendra Lynn Sweet have?
OpenAlex counts 400 works and 5,590 citations for Kendra Lynn Sweet, an h-index of 36, ranking #1,281,949 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kendra Lynn Sweet. Posts are plain text and can be reported.